FROG vs JAZZ · rev $428.5M vs P/E 1988, rev $4.07B
Jfrog Ltd (FROG) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Jfrog Ltd (FROG) is a software - application company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported FROG revenue for 2024-12-31 was $428.5M. Net income was -$69.2M. Revenue was up 22.5% from 2023-12-31 to 2024-12-31. FROG currently screens at market cap $10.44B.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
FROG currently screens at market cap $10.44B. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the FROG and JAZZ stock pages for the full models.
Not investment advice.